Doctor Viktoria Nagy

University of Szeged, Szeged (Hungary)

Membership: EACVI Member HFA Member

Follow

Contributor content

The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment

Presentation

The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment

ESC 365 is supported by

novartis

Explore sponsored resources